
DOUBLE ANEUPLOIDY 48,XXY,+21 ASSOCIATED WITH
A CONGENITAL HEART DEFECT IN A NEONATE Shu X, Zou C, Shen Z* *Corresponding Author: Zheng Shen, M.D., The Children’s Hospital of Zhejiang University School of Medicine,
57 Zhugan Xiang, Hangzhou 310003, People’s Republic of China; Tel.: +86-13575743518; Fax: +86-571-
87033296; E-mail: shenzheng@tom.com page: 85
|
DISCUSSION
Double aneuploidy, the existence of two chromosome
anomalies in the same person, is rare, which
can involve autosomes (chromosome 13, 18 or 21)
and sex chromosomes. The causes of aneuploidy are
not well-documented, however, it is known that the
most common chromosomal mechanism is meiotic
non disjunction. The cause of non disjunction is also
uncertain. Non disjunction can occur during meiosis
I when the chromosome pairs fail to separate or
during meiosis II when chromatids fail to separate.
Generally, the mother contributes the extra chromosome The occurrence of double aneuploidy of DS
combined with KS is unclear, not to mention the
double aneuploidy associated with CHD. Approximately
65 cases of double aneuploidy of XXY and
trisomy 21 have been published since 1959, and
there are only eight cases associated with CHD [12-
14], including our case (Table 1). It is well known
that 40.0-50.0% of patients with DS and half the patients
with KS have CHD [15]. The incidence of cardiovascular
anomalies in patients with 48,XXY,+21
karyo-type is not clear. To the best of our knowledge,
only eight case reports of CHD in these patients
have been published (Table 1). These patients
have less vascular anomalies than the general population,
probably because of an increased inhibition
of vascular endothelial growth factor, whose genes
are located on chromosome 21 [16].
In conclusion, DS-KS syndrome is an extremely
rare condition. We present a case of 48,XXY,+21
karyotype with typical features of DS, whose parents
were very young. Together with the other seven
cases of double aneuploidy associated with CHD,
the maternal ages are different, which do not support
the maternal age effect.
21 in 85.0% and the father in 15.0%, of cases.
However, the extra X chromosome is contributed by
the parents contribution in 50.0% of cases.
Our patient is an infant, who exhibited typical
DS features with a 48,XXY,+21 karyotype, born at term to a 21-year-old mother and 23-year-old father.
It is evident that the risk for trisomy 21 in offspring
increases with maternal age, and the maternal age effect
was also demonstrated in the 47,XXY aneuploidy
[4]. A previous study also suggests women aged
20 through 24 years have the lowest prevalence rate
of DS (1/1400 births), and for women aged 35 years,
the rate is approximately 1/350 births, and for women
over 45 years old, the rate rises to 1/25 births [5-
6]. Thus, maternal age-related factors seem to play a
more important role in the etiology of 48,XXY, +21
than genetic predisposition. Kovaleva and Mutton [4]
reported that the double aneuploidy of 48,XXY,+21 is
age-dependent, with a mean maternal age of 33 and a
mean paternal age of 37.9. However, in our case, the
parents were very young. From the published cases,
we can conclude that the paternal ages are remarkably
different in patients with a double aneuploidy of
48,XXY,+21 associated with CHD (Table 1) [7-13].
The exclusion of advanced maternal age as risk factor
for chromosomal non disjunction in the present
case suggests the existence of other risk factors.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|